{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:18:25Z","timestamp":1792606705133,"version":"4.5.0"},"reference-count":478,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance and recurrent disease are the main obstacles for successful therapy. One of the main reasons for this is the presence of a specific cell population of cancer stem cells. The aim of this review is to show the most contemporary knowledge concerning the biology of ovarian cancer stem cells (OCSCs) and their impact on chemo-resistance and prognosis in ovarian cancer patients, as well as to present the treatment options targeted exclusively on the OCSCs. The review presents data concerning the role of cancer stem cells in general and then concentrates on OCSCs. The surface and intracellular OCSCs markers and their meaning both for cancer biology and clinical prognosis, signaling pathways specifically activated in OCSCs, the genetic and epigenetic regulation of OCSCs function including the recent studies on the non-coding RNA regulation, cooperation between OCSCs and the tumor microenvironment (ovarian cancer niche) including very specific environment such as ascites fluid, the role of shear stress, autophagy and metabolic changes for the function of OCSCs, and finally mechanisms of OCSCs escape from immune surveillance, are described and discussed extensively. The possibilities of anti-OCSCs therapy both in experimental settings and in clinical trials are presented, including the recent II phase clinical trials and immunotherapy. OCSCs are a unique population of cancer cells showing a great plasticity, self-renewal potential and resistance against anti-cancer treatment. They are responsible for the progression and recurrence of the tumor. Several completed and ongoing clinical trials have tested different anti-OCSCs drugs which, however, have shown unsatisfactory efficacy in most cases. We propose a novel approach to ovarian cancer diagnosis and therapy.<\/jats:p>","DOI":"10.3390\/ijms23052496","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T07:22:35Z","timestamp":1645687355000},"page":"2496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cancer Stem Cells in Ovarian Cancer\u2014A Source of Tumor Success and a Challenging Target for Novel Therapies"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-6533","authenticated-orcid":false,"given":"Jacek R","family":"Wilczy\u0144ski","sequence":"first","affiliation":[{"name":"Department of Gynecological Surgery and Gynecological Oncology, Medical University of Lodz, 4 Kosciuszki Str., 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5720-427X","authenticated-orcid":false,"given":"Mi\u0142osz","family":"Wilczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Gynecological, Endoscopic and Oncological Surgery, Polish Mother\u2019s Health Center\u2014Research Institute, 281\/289 Rzgowska Str., 93-338 Lodz, Poland"},{"name":"Department of Surgical and Endoscopic Gynecology, Medical University of Lodz, 4 Kosciuszki Str., 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-0136","authenticated-orcid":false,"given":"Edyta","family":"Paradowska","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Institute of Medical Biology of the Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"ref_1","first-page":"145","article-title":"Clinical Electron Microscopy in the Study of Human Ovarian Tissues","volume":"14","author":"Giusti","year":"2019","journal-title":"Euromediterr. Biomed. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The Dualistic Model of Ovarian Carcinogenesis","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/path.4252","article-title":"KRAS (but Not BRAF ) Mutations in Ovarian Serous Borderline Tumour Are Associated with Recurrent Low-Grade Serous Carcinoma","volume":"231","author":"Tsang","year":"2013","journal-title":"J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt\/\u03b2-Catenin and PI3K\/Pten Signaling Pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1581","article-title":"\u03b2- Catenin Mutations and Aberrant Nuclear Expression during Endometrial Tumorigenesis","volume":"84","author":"Saegusa","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4161\/cbt.5.7.2751","article-title":"Sequence Mutations and Amplification of PIK3CA and AKT2 Genes in Purified Ovarian Serous Neoplasms","volume":"5","author":"Nakayama","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole\u2013Genome Characterization of Chemoresistant Ovarian Cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","article-title":"Molecular Alterations of TP53 Are a Defining Feature of Ovarian High-Grade Serous Carcinoma","volume":"35","author":"Vang","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"(2011). Integrated Genomic Analyses of Ovarian Carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Konecny, G.E., Wang, C., Hamidi, H., Winterhoff, B., Kalli, K.R., Dering, J., Ginther, C., Chen, H.-W., Dowdy, S., and Cliby, W. (2014). Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer. JNCI: J. Natl. Cancer Inst., 106.","DOI":"10.1093\/jnci\/dju249"},{"key":"ref_12","first-page":"833","article-title":"Emerging Insights into the Biology of Metastasis: A Review Article","volume":"22","author":"Irani","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00018-019-03199-x","article-title":"Stem Cells in Tissues, Organoids, and Cancers","volume":"76","author":"Wang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human Acute Myeloid Leukemia Is Organized as a Hierarchy That Originates from a Primitive Hematopoietic Cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41418-019-0292-y","article-title":"Autophagy and Cancer Stem Cells: Molecular Mechanisms and Therapeutic Applications","volume":"26","author":"Nazio","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Capp, J.-P. (2019). Cancer Stem Cells: From Historical Roots to a New Perspective. J. Oncol., 2019.","DOI":"10.1155\/2019\/5189232"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient Tumour Formation by Single Human Melanoma Cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1171837","article-title":"The Increasing Complexity of the Cancer Stem Cell Paradigm","volume":"324","author":"Rosen","year":"2009","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer Stem Cells Revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lee, K.-L., Kuo, Y.-C., Ho, Y.-S., and Huang, Y.-H. (2019). Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers, 11.","DOI":"10.3390\/cancers11091334"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fonc.2019.00167","article-title":"Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)\u2014Is There Still Room for Optimism?","volume":"9","author":"Marcucci","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.oraloncology.2016.10.008","article-title":"Implications of Cancer Stem Cells in Developing Therapeutic Resistance in Oral Cancer","volume":"62","author":"Naik","year":"2016","journal-title":"Oral Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Schmidt, F., and Efferth, T. (2016). Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance. Pharmaceuticals, 9.","DOI":"10.3390\/ph9020033"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/nm.3336","article-title":"The Epigenetics of Epithelial-Mesenchymal Plasticity in Cancer","volume":"19","author":"Tam","year":"2013","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A Restricted Cell Population Propagates Glioblastoma Growth after Chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells","volume":"157","author":"Rheinbay","year":"2014","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CCO.0000000000000503","article-title":"Post-Transcriptional Regulations of Cancer Stem Cell Homeostasis","volume":"31","author":"Berabez","year":"2019","journal-title":"Curr. Opin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.0807146105","article-title":"Sustained Induction of Epithelial to Mesenchymal Transition Activates DNA Methylation of Genes Silenced in Basal-like Breast Cancers","volume":"105","author":"Dumont","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ijc.28572","article-title":"Pushing Tumor Cells towards a Malignant Phenotype: Stimuli from the Microenvironment, Intercellular Communications and Alternative Roads","volume":"135","author":"Marcucci","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt Pathways in Cancer Stem Cells: Clinical Update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Taniguchi, H., Suzuki, Y., and Natori, Y. (2019). The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity. Cancers, 11.","DOI":"10.3390\/cancers11040532"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","article-title":"The Developing Cancer Stem-Cell Model: Clinical Challenges and Opportunities","volume":"13","author":"Vermeulen","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer Stem Cells in Solid Tumours: Accumulating Evidence and Unresolved Questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wallin, J.J., Guan, J., Edgar, K.A., Zhou, W., Francis, R., Torres, A.C., Haverty, P.M., Eastham-Anderson, J., Arena, S., and Bardelli, A. (2012). Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036402"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mazzoldi, E.L., Past\u00f2, A., Pilotto, G., Minuzzo, S., Piga, I., Palumbo, P., Carella, M., Frezzini, S., Nicoletto, M.O., and Amadori, A. (2020). Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020368"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1235226","article-title":"Circulating Tumor Cells","volume":"341","author":"Plaks","year":"2013","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s43018-020-0088-5","article-title":"The Current Paradigm and Challenges Ahead for the Dormancy of Disseminated Tumor Cells","volume":"1","author":"Risson","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2011.07.037","article-title":"Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors","volume":"141","author":"Gaur","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semcancer.2019.09.002","article-title":"Dormant Disseminated Tumor Cells and Cancer Stem\/Progenitor-like Cells: Similarities and Opportunities","volume":"60","author":"Hen","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1073\/pnas.0800939105","article-title":"ATF6-Rheb-MTOR Signaling Promotes Survival of Dormant Tumor Cells in Vivo","volume":"105","author":"Schewe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"de Angelis, M., Francescangeli, F., and Zeuner, A. (2019). Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities. Cancers, 11.","DOI":"10.3390\/cancers11101569"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel Progression of Primary Tumours and Metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of Disseminated Cancer Cell Dormancy: An Awakening Field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1200\/JCO.2008.17.0563","article-title":"Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer","volume":"27","author":"Weckermann","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Jahanban-Esfahlan, R., Seidi, K., Manjili, M.H., Jahanban-Esfahlan, A., Javaheri, T., and Zare, P. (2019). Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers, 11.","DOI":"10.3390\/cancers11081207"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fonc.2019.00082","article-title":"Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells","volume":"9","author":"Ingangi","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Galv\u00e1n, S., and Carnero, A. (2020). Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer. Cells, 9.","DOI":"10.3390\/cells9061402"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-Mediated MDR1 Gene Expression, and Ankyrin-Regulated Multidrug Efflux in Breast and Ovarian Tumor Cells","volume":"283","author":"Bourguignon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1742-4658.2012.08589.x","article-title":"MicroRNA-199a Targets CD44 to Suppress the Tumorigenicity and Multidrug Resistance of Ovarian Cancer-Initiating Cells","volume":"279","author":"Cheng","year":"2012","journal-title":"FEBS J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jbiosc.2014.01.008","article-title":"Observation of Ovarian Cancer Stem Cell Behavior and Investigation of Potential Mechanisms of Drug Resistance in Three-Dimensional Cell Culture","volume":"118","author":"Chen","year":"2014","journal-title":"J. Biosci. Bioeng."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/IGC.0b013e3182a1d023","article-title":"Effects and Mechanisms of Anti-CD44 Monoclonal Antibody A3D8 on Proliferation and Apoptosis of Sphere-Forming Cells With Stemness From Human Ovarian Cancer","volume":"23","author":"Du","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M113.497685","article-title":"CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness","volume":"288","author":"Grass","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-017-0638-3","article-title":"Ovarian Cancer Stem Cells: Still an Elusive Entity?","volume":"16","author":"Lupia","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/AOG.0000000000001420","article-title":"CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer","volume":"127","author":"Motohara","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/cas.12765","article-title":"CD 44 Variant 6 Is Correlated with Peritoneal Dissemination and Poor Prognosis in Patients with Advanced Epithelial Ovarian Cancer","volume":"106","author":"Tjhay","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zong, X., and Nephew, K.P. (2019). Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting. Cancers, 11.","DOI":"10.3390\/cancers11070934"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.stem.2011.01.007","article-title":"Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research","volume":"8","author":"Golebiewska","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/DDDT.S89114","article-title":"Receptor Tyrosine Kinase (c-Kit) Inhibitors: A Potential Therapeutic Target in Cancer Cells","volume":"10","author":"Kamalidehghan","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2012.290","article-title":"C-Kit Mediates Chemoresistance and Tumor-Initiating Capacity of Ovarian Cancer Cells through Activation of Wnt\/\u03b2-Catenin\u2013ATP-Binding Cassette G2 Signaling","volume":"32","author":"Chau","year":"2013","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000356660","article-title":"Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas","volume":"33","author":"He","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","article-title":"Ovarian Cancer Cells with the CD117 Phenotype Are Highly Tumorigenic and Are Related to Chemotherapy Outcome","volume":"91","author":"Luo","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian Cancer Side Population Defines Cells with Stem Cell-like Characteristics and Mullerian Inhibiting Substance Responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","first-page":"3497","article-title":"The Identification of the Biological Characteristics of Human Ovarian Cancer Stem Cells","volume":"18","author":"Yan","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/annonc\/mdh139","article-title":"C-KIT Expression and Correlation with Chemotherapy Resistance in Ovarian Carcinoma: An Immunocytochemical Study","volume":"15","author":"Raspollini","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Li, S.-S., Ma, J., and Wong, A.S.T. (2018). Chemoresistance in Ovarian Cancer: Exploiting Cancer Stem Cell Metabolism. J. Gynecol. Oncol., 29.","DOI":"10.3802\/jgo.2018.29.e32"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41419-019-1656-4","article-title":"A Juxtacrine\/Paracrine Loop between C-Kit and Stem Cell Factor Promotes Cancer Stem Cell Survival in Epithelial Ovarian Cancer","volume":"10","author":"Mazzoldi","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Roy, L., Bobbs, A., Sattler, R., Kurkewich, J.L., Dausinas, P.B., Nallathamby, P., and Cowden Dahl, K.D. (2018). CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche. Cancer Growth Metastasis, 11.","DOI":"10.1177\/1179064418767882"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5114\/wo.2018.73885","article-title":"Surface Markers of Cancer Stem-like Cells of Ovarian Cancer and Their Clinical Relevance","volume":"2018","author":"Klemba","year":"2018","journal-title":"Wsp\u00f3\u0142czesna Onkol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/onc.2013.537","article-title":"Interleukin-17 Produced by Tumor Microenvironment Promotes Self-Renewal of CD133+ Cancer Stem-like Cells in Ovarian Cancer","volume":"34","author":"Xiang","year":"2015","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic Regulation of CD133 and Tumorigenicity of CD133+ Ovarian Cancer Cells","volume":"28","author":"Baba","year":"2009","journal-title":"Oncogene"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/modpathol.2011.170","article-title":"CD133 Expression Associated with Poor Prognosis in Ovarian Cancer","volume":"25","author":"Zhang","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-73359-9_10","article-title":"Ovarian cancer stem cells: Characterization and role in tumorigenesis","volume":"1330","author":"Saha","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/stem.1317","article-title":"CD133 Is Essential for Glioblastoma Stem Cell Maintenance","volume":"31","author":"Brescia","year":"2013","journal-title":"Stem Cells"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E6882","DOI":"10.1073\/pnas.1507899112","article-title":"Identifying an Ovarian Cancer Cell Hierarchy Regulated by Bone Morphogenetic Protein 2","volume":"112","author":"Choi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cioffi, M., D\u2019Alterio, C., Camerlingo, R., Tirino, V., Consales, C., Riccio, A., Ieran\u00f2, C., Cecere, S.C., Losito, N.S., and Greggi, S. (2015). Identification of a Distinct Population of CD133+CXCR4+ Cancer Stem Cells in Ovarian Cancer. Sci. Rep., 5.","DOI":"10.1038\/srep10357"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer","volume":"27","author":"Curley","year":"2009","journal-title":"Stem Cells"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.023","article-title":"CD133 Confers Cancer Stem-like Cell Properties by Stabilizing EGFR-AKT Signaling in Hepatocellular Carcinoma","volume":"389","author":"Jang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of Aldehyde Dehydrogenase and CD133 Defines Ovarian Cancer Stem Cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1073\/pnas.1217002110","article-title":"Activation of PI3K\/Akt Pathway by CD133-P85 Interaction Promotes Tumorigenic Capacity of Glioma Stem Cells","volume":"110","author":"Wei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"E231","DOI":"10.1002\/hed.23975","article-title":"Targeting CD133 in the Enhancement of Chemosensitivity in Oral Squamous Cell Carcinoma-Derived Side Population Cancer Stem Cells","volume":"38","author":"Yu","year":"2016","journal-title":"Head Neck"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3892\/or.2014.3488","article-title":"Overexpression of CD133 Enhances Chemoresistance to 5-Fluorouracil by Activating the PI3K\/Akt\/P70S6K Pathway in Gastric Cancer Cells","volume":"32","author":"ZHU","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Abubaker, K., Luwor, R.B., Zhu, H., McNally, O., Quinn, M.A., Burns, C.J., Thompson, E.W., Findlay, J.K., and Ahmed, N. (2014). Inhibition of the JAK2\/STAT3 Pathway in Ovarian Cancer Results in the Loss of Cancer Stem Cell-like Characteristics and a Reduced Tumor Burden. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-317"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Jain, S., Annett, S.L., Morgan, M.P., and Robson, T. (2021). The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084091"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2014.10.004","article-title":"The Clinical Role of Epithelial-Mesenchymal Transition and Stem Cell Markers in Advanced-Stage Ovarian Serous Carcinoma Effusions","volume":"46","author":"Davidson","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.08.005","article-title":"CD24 Is Highly Useful in Differentiating High-Grade Serous Carcinoma from Benign and Malignant Mesothelial Cells","volume":"58","author":"Davidson","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ Cells from Hierarchically Organized Ovarian Cancer Are Enriched in Cancer Stem Cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jaggupilli, A., and Elkord, E. (2012). Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity. Clin. Dev. Immunol., 2012.","DOI":"10.1155\/2012\/708036"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11596-015-1443-0","article-title":"Role of CD24 in Anoikis Resistance of Ovarian Cancer Cells","volume":"35","author":"Li","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technol. [Med. Sci.]"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3892\/or.2017.5583","article-title":"CD24 Expression Is a Marker for Predicting Clinical Outcome and Regulates the Epithelial-Mesenchymal Transition in Ovarian Cancer via Both the Akt and ERK Pathways","volume":"37","author":"Nakamura","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"58351","DOI":"10.18632\/oncotarget.11113","article-title":"CD44 and CD24 Coordinate the Reprogramming of Nasopharyngeal Carcinoma Cells towards a Cancer Stem Cell Phenotype through STAT3 Activation","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10495-013-0949-9","article-title":"CD24 Mediates Gastric Carcinogenesis and Promotes Gastric Cancer Progression via STAT3 Activation","volume":"19","author":"Wang","year":"2014","journal-title":"Apoptosis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"55663","DOI":"10.18632\/oncotarget.10971","article-title":"CD24 Promoted Cancer Cell Angiogenesis via Hsp90-Mediated STAT3\/VEGF Signaling Pathway in Colorectal Cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival","volume":"161","author":"Kristiansen","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"d\u2019Adhemar, C.J., Spillane, C.D., Gallagher, M.F., Bates, M., Costello, K.M., Barry-O\u2019Crowley, J., Haley, K., Kernan, N., Murphy, C., and Smyth, P.C. (2014). The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100816"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13048-019-0588-z","article-title":"Ovarian Cancer Stem Cells and Targeted Therapy","volume":"12","author":"Keyvani","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1292\/jvms.20-0455","article-title":"Chimeric Antigen Receptor-T (CAR-T) Cells Targeting Epithelial Cell Adhesion Molecule (EpCAM) Can Inhibit Tumor Growth in Ovarian Cancer Mouse Model","volume":"83","author":"FU","year":"2021","journal-title":"J. Vet. Med. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/bgr183","article-title":"Transient Depletion of P53 Followed by Transduction of C-Myc and K-Ras Converts Ovarian Stem-like Cells into Tumor-Initiating Cells","volume":"32","author":"Motohara","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1535-7163.MCT-11-0693","article-title":"Navitoclax (ABT-263) Reduces Bcl-x L \u2013Mediated Chemoresistance in Ovarian Cancer Models","volume":"11","author":"Wong","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer Stem Cells from Epithelial Ovarian Cancer Patients Privilege Oxidative Phosphorylation, and Resist Glucose Deprivation","volume":"5","author":"Bellio","year":"2014","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Jung, J.-G., Stoeck, A., Guan, B., Wu, R.-C., Zhu, H., Blackshaw, S., Shih, I.-M., and Wang, T.-L. (2014). Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004751"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24\u2212 Ovarian Cancer Cells Demonstrate Cancer Stem Cell Properties and Correlate to Survival","volume":"29","author":"Meng","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Steffensen, K.D., Alvero, A.B., Yang, Y., Waldstr\u00f8m, M., Hui, P., Holmberg, J.C., Silasi, D.-A., Jakobsen, A., Rutherford, T., and Mor, G. (2011). Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer. J. Oncol., 2011.","DOI":"10.1155\/2011\/620523"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Testa, U., Petrucci, E., Pasquini, L., Castelli, G., and Pelosi, E. (2018). Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines, 5.","DOI":"10.3390\/medicines5010016"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/stem.191","article-title":"Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors","volume":"27","author":"Alvero","year":"2009","journal-title":"Stem Cells"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/onc.2016.337","article-title":"Identification of a Cancer Stem Cell-Specific Function for the Histone Deacetylases, HDAC1 and HDAC7, in Breast and Ovarian Cancer","volume":"36","author":"Witt","year":"2017","journal-title":"Oncogene"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/onc.2012.33","article-title":"Constitutive Proteasomal Degradation of TWIST-1 in Epithelial\u2013Ovarian Cancer Stem Cells Impacts Differentiation and Metastatic Potential","volume":"32","author":"Yin","year":"2013","journal-title":"Oncogene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human Ovarian Cancer Stem\/Progenitor Cells Are Stimulated by Doxorubicin but Inhibited by Mullerian Inhibiting Substance","volume":"109","author":"Meirelles","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"16437","DOI":"10.18632\/oncotarget.4103","article-title":"Accumulation of ALDH1-Positive Cells after Neoadjuvant Chemotherapy Predicts Treatment Resistance and Prognosticates Poor Outcome in Ovarian Cancer","volume":"6","author":"Ayub","year":"2015","journal-title":"Oncotarget"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","article-title":"Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer","volume":"34","author":"Meyer","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.18632\/oncotarget.2053","article-title":"The Side Population of Ovarian Cancer Cells Defines a Heterogeneous Compartment Exhibiting Stem Cell Characteristics","volume":"5","author":"Boesch","year":"2014","journal-title":"Oncotarget"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1158\/0008-5472.CAN-17-0366","article-title":"NF\u03baB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem\u2013like Cells","volume":"77","author":"House","year":"2017","journal-title":"Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.10.024","article-title":"Predictive Markers of Chemoresistance in Advanced Stages Epithelial Ovarian Carcinoma","volume":"136","author":"Bonneau","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","article-title":"\u03b2-Catenin-Regulated ALDH1A1 Is a Target in Ovarian Cancer Spheroids","volume":"34","author":"Condello","year":"2015","journal-title":"Oncogene"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biocel.2016.07.017","article-title":"Inhibition of ALDH1A1 Activity Decreases Expression of Drug Transporters and Reduces Chemotherapy Resistance in Ovarian Cancer Cell Lines","volume":"78","author":"Januchowski","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Kuroda, T., Hirohashi, Y., Torigoe, T., Yasuda, K., Takahashi, A., Asanuma, H., Morita, R., Mariya, T., Asano, T., and Mizuuchi, M. (2013). ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065158"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Meng, E., Mitra, A., Tripathi, K., Finan, M.A., Scalici, J., McClellan, S., da Silva, L.M., Reed, E., Shevde, L.A., and Palle, K. (2014). ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107142"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","article-title":"Ovarian Cancer Stem Cells More Questions than Answers","volume":"44","author":"Ottevanger","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"ref_123","first-page":"3425","article-title":"Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-Treated Patients with Ovarian Cancer","volume":"36","author":"Liakka","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Motohara, T., and Katabuchi, H. (2019). Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance. Cancers, 11.","DOI":"10.3390\/cancers11070907"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Deng, S., Yang, X., Lassus, H., Liang, S., Kaur, S., Ye, Q., Li, C., Wang, L.-P., Roby, K.F., and Orsulic, S. (2010). Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010277"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.humpath.2012.12.016","article-title":"Aldehyde Dehydrogenase 1\/Epidermal Growth Factor Receptor Coexpression Is Characteristic of a Highly Aggressive, Poor-Prognosis Subgroup of High-Grade Serous Ovarian Carcinoma","volume":"44","author":"Liebscher","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2014.12.005","article-title":"Cancer Stem-like Cells of Ovarian Clear Cell Carcinoma Are Enriched in the ALDH-High Population Associated with an Accelerated Scavenging System in Reactive Oxygen Species","volume":"137","author":"Mizuno","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1007\/s13277-015-3561-5","article-title":"Overexpression of SOX2 Is Involved in Paclitaxel Resistance of Ovarian Cancer via the PI3K\/Akt Pathway","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cas.13186","article-title":"SOX2 Is Required to Maintain Cancer Stem Cells in Ovarian Cancer","volume":"108","author":"Wen","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1101\/gad.1606308","article-title":"Oct4 Dependence of Chromatin Structure within the Extended Nanog Locus in ES Cells","volume":"22","author":"Levasseur","year":"2008","journal-title":"Genes Dev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","article-title":"Pluripotency Factors Lin28 and Oct4 Identify a Sub-Population of Stem Cell-like Cells in Ovarian Cancer","volume":"29","author":"Peng","year":"2010","journal-title":"Oncogene"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13402-013-0142-8","article-title":"The Stem Cell Markers Oct4A, Nanog and c-Myc Are Expressed in Ascites Cells and Tumor Tissue of Ovarian Cancer Patients","volume":"36","author":"Di","year":"2013","journal-title":"Cell. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-1130-z","article-title":"Downregulation of MYPT1 Increases Tumor Resistance in Ovarian Cancer by Targeting the Hippo Pathway and Increasing the Stemness","volume":"19","author":"Perez","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.18632\/oncotarget.4280","article-title":"FOXM1 Is a Downstream Target of LPA and YAP Oncogenic Signaling Pathways in High Grade Serous Ovarian Cancer","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"23720","DOI":"10.18632\/oncotarget.4690","article-title":"Critical Role of Wnt\/\u03b2-Catenin Signaling in Driving Epithelial Ovarian Cancer Platinum Resistance","volume":"6","author":"Nagaraj","year":"2015","journal-title":"Oncotarget"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Zhou, J., Wang, Y., Wang, Y., Yin, X., He, Y., Chen, L., Wang, W., Liu, T., and Di, W. (2014). FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096989"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/PGP.0b013e3182800ad5","article-title":"The Stem-Cell Profile of Ovarian Surface Epithelium Is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae","volume":"32","author":"Auersperg","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian Surface Epithelium at the Junction Area Contains a Cancer-Prone Stem Cell Niche","volume":"495","author":"Hwang","year":"2013","journal-title":"Nature"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1933719112461183","article-title":"High Frequency of Putative Ovarian Cancer Stem Cells With CD44\/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer","volume":"20","author":"Liu","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.humpath.2013.02.016","article-title":"CD44 Standard Form Expression Is Correlated with High-Grade and Advanced-Stage Ovarian Carcinoma but Not Prognosis","volume":"44","author":"Zhang","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"050","DOI":"10.1055\/s-0041-1724235","article-title":"A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and Their Correlation with P53 And Ki67","volume":"13","author":"Kar","year":"2021","journal-title":"J. Lab. Physicians"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/mmr.2021.12274","article-title":"Chemokine CCL20 Promotes the Paclitaxel Resistance of CD44 + CD117 + Cells via the Notch1 Signaling Pathway in Ovarian Cancer","volume":"24","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","article-title":"Identification of Cancer Stem Cell-like Cells from Human Epithelial Ovarian Carcinoma Cell Line","volume":"67","author":"Shi","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-021-01993-x","article-title":"LncRNA WDFY3-AS2 Promotes Cisplatin Resistance and the Cancer Stem Cell in Ovarian Cancer by Regulating Hsa-MiR-139-5p\/SDC4 Axis","volume":"21","author":"Wu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2011.11.015","article-title":"ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome","volume":"180","author":"Wang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1634\/stemcells.2008-0868","article-title":"CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor Vasculature","volume":"27","author":"Kusumbe","year":"2009","journal-title":"Stem Cells"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Ferrandina, G., Martinelli, E., Petrillo, M., Prisco, M.G., Zannoni, G., Sioletic, S., and Scambia, G. (2009). CD133 Antigen Expression in Ovarian Cancer. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-221"},{"key":"ref_148","first-page":"745","article-title":"Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases","volume":"39","year":"2015","journal-title":"Coll. Antropol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4149\/neo_2012_040","article-title":"Expression of Putative Stem Marker Nestin and CD133 in Advanced Serous Ovarian Cancer","volume":"59","author":"Qin","year":"2012","journal-title":"Neoplasma"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejca.2017.04.016","article-title":"Exploring the Clonal Evolution of CD133\/Aldehyde-Dehydrogenase-1 (ALDH1)-Positive Cancer Stem-like Cells from Primary to Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Study of the Ovarian Cancer Therapy\u2013Innovative Models Prolong Survival (OCTIPS) Consortium","volume":"79","author":"Ruscito","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","article-title":"Ovarian Cancer Stem-like Side-Population Cells Are Tumourigenic and Chemoresistant","volume":"102","author":"Hu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ygyno.2010.12.366","article-title":"Side Population Is Increased in Paclitaxel-Resistant Ovarian Cancer Cell Lines Regardless of Resistance to Cisplatin","volume":"121","author":"Kobayashi","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0501-y","article-title":"Notch2 Pathway Mediates Breast Cancer Cellular Dormancy and Mobilisation in Bone and Contributes to Haematopoietic Stem Cell Mimicry","volume":"121","author":"Capulli","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.18632\/oncotarget.24784","article-title":"RANTES and IL-6 Cooperate in Inducing a More Aggressive Phenotype in Breast Cancer Cells","volume":"9","author":"Gallo","year":"2018","journal-title":"Oncotarget"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Kim, T., Yang, S.-J., Hwang, D., Song, J., Kim, M., Kyum Kim, S., Kang, K., Ahn, J., Lee, D., and Kim, M. (2015). A Basal-like Breast Cancer-Specific Role for SRF\u2013IL6 in YAP-Induced Cancer Stemness. Nat. Commun., 6.","DOI":"10.1038\/ncomms10186"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cas.13147","article-title":"Hypoxia Promotes the Phenotypic Change of Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells","volume":"108","author":"Shiraishi","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Sulaiman, A., McGarry, S., Han, X., Liu, S., and Wang, L. (2019). CSCs in Breast Cancer\u2014One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs. Cancers, 11.","DOI":"10.3390\/cancers11081128"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00005-011-0131-4","article-title":"Targeting NF-\u039aB and HIF-1 Pathways for the Treatment of Cancer: Part I","volume":"59","author":"Wilczynski","year":"2011","journal-title":"Arch. Immunol. Et Ther. Exp."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00005-011-0132-3","article-title":"Targeting NF-\u039aB and HIF-1 Pathways for the Treatment of Cancer: Part II","volume":"59","author":"Wilczynski","year":"2011","journal-title":"Arch. Immunol. Et Ther. Exp."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Teeuwssen, M., and Fodde, R. (2019). Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101658"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.18632\/oncotarget.20178","article-title":"LGR5 and LGR6 in Stem Cell Biology and Ovarian Cancer","volume":"9","author":"Schindler","year":"2018","journal-title":"Oncotarget"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1038\/onc.2016.15","article-title":"Cyclin G2 Inhibits Epithelial-to-Mesenchymal Transition by Disrupting Wnt\/\u03b2-Catenin Signaling","volume":"35","author":"Bernaudo","year":"2016","journal-title":"Oncogene"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic Silencing of SFRP5 Is Related to Malignant Phenotype and Chemoresistance of Ovarian Cancer through Wnt Signaling Pathway","volume":"127","author":"Su","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41467-018-07987-0","article-title":"Dickkopf-3 Links HSF1 and YAP\/TAZ Signalling to Control Aggressive Behaviours in Cancer-Associated Fibroblasts","volume":"10","author":"Ferrari","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian Cancer Stem Cells and Macrophages Reciprocally Interact through the WNT Pathway to Promote Pro-Tumoral and Malignant Phenotypes in 3D Engineered Microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J. ImmunoTherapy Cancer"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1042\/CS20190082","article-title":"Ovarian Cancer-Derived Exosomes Promote Tumour Metastasis in Vivo: An Effect Modulated by the Invasiveness Capacity of Their Originating Cells","volume":"133","author":"Alharbi","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_167","first-page":"2391","article-title":"Identification of Common Differentially-expressed MiRNAs in Ovarian Cancer Cells and Their Exosomes Compared with Normal Ovarian Surface Epithelial Cell Cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","article-title":"Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin","volume":"177","author":"Park","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_169","first-page":"797","article-title":"Hedgehog Signaling Pathway Regulates the Growth of Ovarian Cancer Spheroid Forming Cells","volume":"39","author":"Rocconi","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_170","first-page":"5569","article-title":"Activation of Hedgehog Signaling and Its Association with Cisplatin Resistance in Ovarian Epithelial Tumors","volume":"15","author":"Song","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_171","first-page":"625","article-title":"Hedgehog Signaling Regulates Drug Sensitivity by Targeting ABC Transporters ABCB1 and ABCG2 in Epithelial Ovarian Cancer","volume":"53","author":"Chen","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites Modulates Cancer Cell Behavior, Contributing to Tumor Heterogeneity in Ovarian Cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch, a Key Pathway for Ovarian Cancer Stem Cells, Sensitizes Tumors to Platinum Therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.21037\/atm-20-4497","article-title":"NOTCH Signalling in Ovarian Cancer Angiogenesis","volume":"8","author":"Ortega","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.arcmed.2017.08.001","article-title":"NF-\u039aB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells","volume":"48","author":"Zampedri","year":"2017","journal-title":"Arch. Med. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/onc.2013.10","article-title":"NF-\u039aB Is a Critical Mediator of BRCA1-Induced Chemoresistance","volume":"33","author":"Harte","year":"2014","journal-title":"Oncogene"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Kaltschmidt, C., Banz-Jansen, C., Benhidjeb, T., Beshay, M., F\u00f6rster, C., Greiner, J., Hamelmann, E., Jorch, N., Mertzlufft, F., and Pfitzenmaier, J. (2019). A Role for NF-\u039aB in Organ Specific Cancer and Cancer Stem Cells. Cancers, 11.","DOI":"10.3390\/cancers11050655"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.canep.2013.02.008","article-title":"Salinomycin Inhibits Akt\/NF-\u039aB and Induces Apoptosis in Cisplatin Resistant Ovarian Cancer Cells","volume":"37","author":"Parajuli","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"(2019). Bregenzer; Horst; Mehta; Novak; Repetto; Mehta The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis. Cancers, 11.","DOI":"10.3390\/cancers11071008"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-\u03b2 Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133 + Ovarian Cancer Stem-Like Cells via NF-\u03baB-Mediated MMP-9 Upregulation","volume":"30","author":"Long","year":"2012","journal-title":"STEM CELLS"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2016.03.034","article-title":"Ovarian Cancer Stem-like Cells Differentiate into Endothelial Cells and Participate in Tumor Angiogenesis through Autocrine CCL5 Signaling","volume":"376","author":"Tang","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Varas-Godoy, M., Rice, G., and Illanes, S.E. (2017). The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment. Stem Cells Int., 2017.","DOI":"10.1155\/2017\/5263974"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"76006","DOI":"10.18632\/oncotarget.12579","article-title":"Autocrine Interleukin-23 Promotes Self-Renewal of CD133+ Ovarian Cancer Stem-like Cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/cc.23406","article-title":"TLR2 Enhances Ovarian Cancer Stem Cell Self-Renewal and Promotes Tumor Repair and Recurrence","volume":"12","author":"Chefetz","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.3748\/wjg.v22.i30.6841","article-title":"Cancer-Associated Fibroblasts in Hepatocellular Carcinoma","volume":"22","author":"Kubo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/onc.2016.404","article-title":"Serglycin in Tumor Microenvironment Promotes Non-Small Cell Lung Cancer Aggressiveness in a CD44-Dependent Manner","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"ref_189","first-page":"691","article-title":"Cancer-associated Fibroblasts Regulate the Biological Behavior of Cancer Cells and Stroma in Gastric Cancer (Review)","volume":"15","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1568009615666150126154151","article-title":"Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases","volume":"15","author":"Chang","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"158","DOI":"10.18632\/oncoscience.381","article-title":"Mesenchymal Stem Cells in Breast Cancer: Response to Chemical and Mechanical Stimuli","volume":"4","author":"Ishihara","year":"2017","journal-title":"Oncoscience"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of Mesenchymal Stem Cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1101\/gad.305292.117","article-title":"Metabolic Reprogramming Ensures Cancer Cell Survival despite Oncogenic Signaling Blockade","volume":"31","author":"Lue","year":"2017","journal-title":"Genes Dev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4252\/wjsc.v11.i9.693","article-title":"Bioactive Lipids in Cancer Stem Cells","volume":"11","author":"Begicevic","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12307-019-00222-4","article-title":"Mechanobiology of Cancer Stem Cells and Their Niche","volume":"12","author":"Gupta","year":"2019","journal-title":"Cancer Microenviron."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fphar.2019.00203","article-title":"Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells","volume":"10","author":"Jagust","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.28583","article-title":"Triptolide Reverses Hypoxia-induced Epithelial\u2013Mesenchymal Transition and Stem-like Features in Pancreatic Cancer by NF-\u03baB Downregulation","volume":"134","author":"Liu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-Inducible Factors and the Response to Hypoxic Stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2019.00159","article-title":"Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche","volume":"9","author":"Corbet","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2016.06.048","article-title":"Premalignant SOX2 Overexpression in the Fallopian Tubes of Ovarian Cancer Patients: Discovery and Validation Studies","volume":"10","author":"Hellner","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","article-title":"Stem-Like Epithelial Cells Are Concentrated in the Distal End of the Fallopian Tube: A Site for Injury and Serous Cancer Initiation","volume":"30","author":"Paik","year":"2012","journal-title":"STEM CELLS"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.4649","article-title":"In Vitro and in Vivo Correlates of Physiological and Neoplastic Human Fallopian Tube Stem Cells","volume":"238","author":"Yamamoto","year":"2016","journal-title":"J. Pathol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and Molecular Processes in Ovarian Cancer Metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W.J., Lele, S.B., and Morrison, C.D. (2014). Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084941"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-04-1800","article-title":"Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles","volume":"64","author":"Graves","year":"2004","journal-title":"Cancer Res."},{"key":"ref_206","first-page":"1108","article-title":"Analysis of Chemokines and Chemokine Receptor Expression in Ovarian Cancer Ascites","volume":"8","author":"Milliken","year":"2002","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13048-018-0391-2","article-title":"Comparison of Benign Peritoneal Fluid- and Ovarian Cancer Ascites-Derived Extracellular Vesicle RNA Biomarkers","volume":"11","author":"Yamamoto","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1158\/1078-0432.CCR-04-1688","article-title":"Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells","volume":"11","author":"Gutwein","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant Ascites-Derived Exosomes of Ovarian Carcinoma Patients Contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Ip, C.K.M., Li, S.-S., Tang, M.Y.H., Sy, S.K.H., Ren, Y., Shum, H.C., and Wong, A.S.T. (2016). Stemness and Chemoresistance in Epithelial Ovarian Carcinoma Cells under Shear Stress. Sci. Rep., 6.","DOI":"10.1038\/srep26788"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1038\/onc.2011.656","article-title":"Acquired Cancer Stem Cell Phenotypes through Oct4-Mediated Dedifferentiation","volume":"31","author":"Kumar","year":"2012","journal-title":"Oncogene"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The MiR-200 Family Determines the Epithelial Phenotype of Cancer Cells by Targeting the E-Cadherin Repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1096\/fj.09-145102","article-title":"RhoA\/ROCK Signaling Is Essential for Multiple Aspects of VEGF-mediated Angiogenesis","volume":"24","author":"Bryan","year":"2010","journal-title":"FASEB J."},{"key":"ref_214","first-page":"2621","article-title":"Metastatic Ovarian Cancer Cell Malignancy Is Increased on Soft Matrices through a Mechanosensitive Rho\/ROCK Pathway","volume":"127","author":"McGrail","year":"2014","journal-title":"J. Cell Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/neup.12117","article-title":"Type 1 Collagen as a Potential Niche Component for CD133-Positive Glioblastoma Cells","volume":"34","author":"Motegi","year":"2014","journal-title":"Neuropathology"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Klymenko, Y., Kim, O., and Stack, M. (2017). Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer. Cancers, 9.","DOI":"10.3390\/cancers9080104"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_218","first-page":"2105","article-title":"Mesothelial cells facilitate cancer stem-like properties in spheroids of ovarian cancer cells","volume":"40","author":"Shishido","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Klymenko, Y., and Nephew, K.P. (2018). Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. Cancers, 10.","DOI":"10.3390\/cancers10090295"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic Acid Is Constitutively Produced by Human Peritoneal Mesothelial Cells and Enhances Adhesion, Migration, and Invasion of Ovarian Cancer Cells","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ygyno.2005.02.017","article-title":"Ovarian Carcinoma Cells and IL-1\u03b2-Activated Human Peritoneal Mesothelial Cells Are Possible Sources of Vascular Endothelial Growth Factor in Inflammatory and Malignant Peritoneal Effusions","volume":"97","author":"Stadlmann","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-0215(19960927)68:1<34::AID-IJC7>3.0.CO;2-Y","article-title":"Circulating Immunostimulatory Protein 90K and Soluble Interleukin-2-Receptor in Human Ovarian Cancer","volume":"68","author":"Zeimet","year":"1996","journal-title":"Int. J. Cancer"},{"key":"ref_223","first-page":"4507","article-title":"Peritoneal Mesothelial Cells as a Significant Source of Ascitic Immunostimulatory Protein 90K","volume":"20","author":"Zeimet","year":"2000","journal-title":"Anticancer Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating Tumor Cells Predict Progression Free Survival and Overall Survival in Patients with Relapsed\/Recurrent Advanced Ovarian Cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgr230","article-title":"Fibroblasts in Omentum Activated by Tumor Cells Promote Ovarian Cancer Growth, Adhesion and Invasiveness","volume":"33","author":"Cai","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/cancers7040872","article-title":"The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis","volume":"7","author":"Sandoval","year":"2015","journal-title":"Cancers"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/path.4889","article-title":"Mesothelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Peritoneal Metastasis of Ovarian Cancer","volume":"242","author":"Yeung","year":"2017","journal-title":"J. Pathol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-Associated Fibroblasts Derive from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Peritoneal Metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J. Pathol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian Cancer-Associated Fibroblasts Contribute to Epithelial Ovarian Carcinoma Metastasis by Promoting Angiogenesis, Lymphangiogenesis and Tumor Cell Invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","article-title":"MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer","volume":"2","author":"Mitra","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4161\/15592294.2014.971608","article-title":"TGF-\u03b2 Induces Global Changes in DNA Methylation during the Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cells","volume":"9","author":"Cardenas","year":"2014","journal-title":"Epigenetics"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Deying, W., Feng, G., Shumei, L., Hui, Z., Ming, L., and Hongqing, W. (2017). CAF-Derived HGF Promotes Cell Proliferation and Drug Resistance by up-Regulating the c-Met\/PI3K\/Akt and GRP78 Signalling in Ovarian Cancer Cells. Biosci. Rep., 37.","DOI":"10.1042\/BSR20160470"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/onc.2013.539","article-title":"Effective Inhibition of C-MET-Mediated Signaling, Growth and Migration of Ovarian Cancer Cells Is Influenced by the Ovarian Tissue Microenvironment","volume":"34","author":"Kwon","year":"2015","journal-title":"Oncogene"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Singh, R.K., Dhadve, A., Sakpal, A., De, A., and Ray, P. (2016). An Active IGF-1R-AKT Signaling Imparts Functional Heterogeneity in Ovarian CSC Population. Sci. Rep., 6.","DOI":"10.1038\/srep36612"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"304","DOI":"10.15252\/emmm.201606840","article-title":"VEGFA Activates an Epigenetic Pathway Upregulating Ovarian Cancer-initiating Cells","volume":"9","author":"Jang","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The Biology and Function of Fibroblasts in Cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"67315","DOI":"10.18632\/oncotarget.18621","article-title":"Human CAFs Promote Lymphangiogenesis in Ovarian Cancer via the Hh-VEGF-C Signaling Axis","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"ref_239","first-page":"2173","article-title":"Role of Cancer-Associated Fibroblasts in Tumor Structure, Composition and the Microenvironment in Ovarian Cancer (Review)","volume":"18","author":"Sun","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose Tissue as an Endocrine Organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes Promote Ovarian Cancer Metastasis and Provide Energy for Rapid Tumor Growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Winiarski, B.K., Wolanska, K.I., Rai, S., Ahmed, T., Acheson, N., Gutowski, N.J., and Whatmore, J.L. (2013). Epithelial Ovarian Cancer-Induced Angiogenic Phenotype of Human Omental Microvascular Endothelial Cells May Occur Independently of VEGF Signaling. Transl. Oncol., 6.","DOI":"10.1593\/tlo.13529"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils Facilitate Ovarian Cancer Premetastatic Niche Formation in the Omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","article-title":"Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance","volume":"80","author":"Mukherjee","year":"2020","journal-title":"Cancer Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.stem.2017.02.008","article-title":"Unsaturated Fatty Acids Maintain Cancer Cell Stemness","volume":"20","author":"Mukherjee","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21037\/sci.2017.05.07","article-title":"Unsaturated Fatty Acids Regulate Stemness of Ovarian Cancer Cells through NF-\u039aB","volume":"4","author":"Parrales","year":"2017","journal-title":"Stem Cell Investig."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semcancer.2018.10.002","article-title":"Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells","volume":"53","author":"Ahmed","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.stem.2016.11.004","article-title":"Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00211.2018","article-title":"Let-7c Regulates Proliferation and Osteodifferentiation of Human Adipose-Derived Mesenchymal Stem Cells under Oxidative Stress by Targeting SCD-1","volume":"316","author":"Zhou","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of Fatty Acid Synthase and HER2 Are Correlated with Poor Prognosis of Ovarian Cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2011.08.005","article-title":"Exosomes from Ovarian Cancer Cells Induce Adipose Tissue-Derived Mesenchymal Stem Cells to Acquire the Physical and Functional Characteristics of Tumor-Supporting Myofibroblasts","volume":"123","author":"Cho","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human Carcinoma-Associated Mesenchymal Stem Cells Promote Ovarian Cancer Chemotherapy Resistance via a BMP4\/HH Signaling Loop","volume":"7","author":"Coffman","year":"2016","journal-title":"Oncotarget"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ijc.25619","article-title":"Tumor Associated Mesenchymal Stem Cells Protects Ovarian Cancer Cells from Hyperthermia through CXCL12","volume":"128","author":"Lis","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"MacLean, J.A., King, M.L., Okuda, H., and Hayashi, K. (2016). WNT7A Regulation by MiR-15b in Ovarian Cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156109"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Spaeth, E.L., Dembinski, J.L., Sasser, A.K., Watson, K., Klopp, A., Hall, B., Andreeff, M., and Marini, F. (2009). Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004992"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1479-5876-11-28","article-title":"Mesenchymal Stem Cells Enhance Ovarian Cancer Cell Infiltration through IL6 Secretion in an Amniochorionic Membrane Based 3D Model","volume":"11","author":"Touboul","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1084\/jem.20151665","article-title":"Metronomic Chemotherapy Prevents Therapy-Induced Stromal Activation and Induction of Tumor-Initiating Cells","volume":"213","author":"Chan","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in Cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15283\/ijsc.2009.2.1.59","article-title":"Cytokine Secretion Profiling of Human Mesenchymal Stem Cells by Antibody Array","volume":"2","author":"Park","year":"2009","journal-title":"Int. J. Stem Cells"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Rafii, A., Mirshahi, P., Poupot, M., Faussat, A.-M., Simon, A., Ducros, E., Mery, E., Couderc, B., Lis, R., and Capdet, J. (2008). Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003894"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/OTT.S145864","article-title":"ALDH1A2 Suppresses Epithelial Ovarian Cancer Cell Proliferation and Migration by Downregulating STAT3","volume":"11","author":"Wang","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41388-018-0523-6","article-title":"Leukemia Inhibitory Factor Functions in Parallel with Interleukin-6 to Promote Ovarian Cancer Growth","volume":"38","author":"McLean","year":"2019","journal-title":"Oncogene"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1172\/JCI45273","article-title":"Human Ovarian Carcinoma\u2013Associated Mesenchymal Stem Cells Regulate Cancer Stem Cells and Tumorigenesis via Altered BMP Production","volume":"121","author":"McLean","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.24886","article-title":"Hospicells (Ascites-Derived Stromal Cells) Promote Tumorigenicity and Angiogenesis","volume":"126","author":"Pasquet","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Bu, S., Wang, Q., Zhang, Q., Sun, J., He, B., Xiang, C., Liu, Z., and Lai, D. (2016). Human Endometrial Mesenchymal Stem Cells Exhibit Intrinsic Anti-Tumor Properties on Human Epithelial Ovarian Cancer Cells. Sci. Rep., 6.","DOI":"10.1038\/srep37019"},{"key":"ref_266","first-page":"2506","article-title":"Systemic Mesenchymal Stem Cells Reduce Growth Rate of Cisplatin-Resistant Ovarian Cancer","volume":"6","author":"Zhu","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/or.2017.5697","article-title":"Exosomes Derived from Hypoxic Epithelial Ovarian Cancer Deliver MicroRNA-940 to Induce Macrophage M2 Polarization","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-Associated Macrophages Drive Spheroid Formation during Early Transcoelomic Metastasis of Ovarian Cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2007-02-072587","article-title":"Tumor-Associated Leukemia Inhibitory Factor and IL-6 Skew Monocyte Differentiation into Tumor-Associated Macrophage-like Cells","volume":"110","author":"Duluc","year":"2007","journal-title":"Blood"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression","volume":"7","author":"Zamarron","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of Vascular Endothelial Growth Factor in Growth and Peritoneal Dissemination of Ovarian Cancer","volume":"31","author":"Amini","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1080\/15384047.2018.1564567","article-title":"M2-like Tumor-Associated Macrophages-Secreted EGF Promotes Epithelial Ovarian Cancer Metastasis via Activating EGFR-ERK Signaling and Suppressing LncRNA LIMT Expression","volume":"20","author":"Zeng","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Gobbo, J., Marcion, G., Cordonnier, M., Dias, A.M.M., Pernet, N., Hammann, A., Richaud, S., Mjahed, H., Isambert, N., and Clausse, V. (2016). Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer. J. Natl. Cancer Inst., 108.","DOI":"10.1093\/jnci\/djv330"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","article-title":"TNF-\u03b1\/NF-\u039aB\/Snail Pathway in Cancer Cell Migration and Invasion","volume":"102","author":"Wu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1189\/jlb.0705395","article-title":"The Immunoregulatory Effects of Gangliosides Involve Immune Deviation Favoring Type-2 T Cell Responses","volume":"79","author":"Crespo","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"ref_277","first-page":"113","article-title":"Indoleamine 2,3-Dioxygenase Promotes Peritoneal Dissemination of Ovarian Cancer through Inhibition of Natural Killercell Function and Angiogenesis Promotion","volume":"38","author":"Nonaka","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ajpath.2011.11.029","article-title":"Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment","volume":"180","author":"Akiyama","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.bjc.6690416","article-title":"Evidence for Characteristic Vascular Patterns in Solid Tumours: Quantitative Studies Using Corrosion Casts","volume":"80","author":"Konerding","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/0008-5472.CAN-06-3700","article-title":"Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","article-title":"Genes That Distinguish Physiological and Pathological Angiogenesis","volume":"11","author":"Seaman","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Ribeiro, A.L., and Okamoto, O.K. (2015). Combined Effects of Pericytes in the Tumor Microenvironment. Stem Cells Int., 2015.","DOI":"10.1155\/2015\/868475"},{"key":"ref_283","first-page":"519","article-title":"Expression of Hexokinase 2 in Epithelial Ovarian Tumors and Its Clinical Significance in Serous Ovarian Cancer","volume":"35","author":"Jin","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10238-013-0250-9","article-title":"Association of Overexpression of Hexokinase II with Chemoresistance in Epithelial Ovarian Cancer","volume":"14","author":"Suh","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/sj.bjc.6604306","article-title":"An Immunohistochemical Perspective of PPAR\u03b2 and One of Its Putative Targets PDK1 in Normal Ovaries, Benign and Malignant Ovarian Tumours","volume":"98","author":"Ahmed","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2008.01.006","article-title":"Mitochondria in Cancer Cells: What Is so Special about Them?","volume":"18","author":"Gogvadze","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"28882","DOI":"10.18632\/oncotarget.4921","article-title":"MiR-1207 Overexpression Promotes Cancer Stem Cell-like Traits in Ovarian Cancer by Activating the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Pagotto, A., Pilotto, G., Mazzoldi, E.L., Nicoletto, M.O., Frezzini, S., Past\u00f2, A., and Amadori, A. (2017). Autophagy Inhibition Reduces Chemoresistance and Tumorigenic Potential of Human Ovarian Cancer Stem Cells. Cell Death Dis., 8.","DOI":"10.1038\/cddis.2017.327"},{"key":"ref_289","doi-asserted-by":"crossref","unstructured":"Ahmed, N., Kadife, E., Raza, A., Short, M., Jubinsky, P.T., and Kannourakis, G. (2020). Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods. Cells, 9.","DOI":"10.3390\/cells9030719"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-Term Single Treatment of Chemotherapy Results in the Enrichment of Ovarian Cancer Stem Cell-like Cells Leading to an Increased Tumor Burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"16599","DOI":"10.18632\/oncotarget.24615","article-title":"Momelotinib Decreased Cancer Stem Cell Associated Tumor Burden and Prolonged Disease-Free Remission Period in a Mouse Model of Human Ovarian Cancer","volume":"9","author":"Chan","year":"2018","journal-title":"Oncotarget"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/hmg\/ddq002","article-title":"Role of Magmas in Protein Transport and Human Mitochondria Biogenesis","volume":"19","author":"Sinha","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour Acidosis: From the Passenger to the Driver\u2019s Seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/cdd.2010.150","article-title":"Acidic Stress Promotes a Glioma Stem Cell Phenotype","volume":"18","author":"Hjelmeland","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ncb1144","article-title":"HIF Activation by PH-Dependent Nucleolar Sequestration of VHL","volume":"6","author":"Mekhail","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1476-5586(03)80005-2","article-title":"Contributions of Cell Metabolism and H+ Diffusion to the Acidic PH of Tumors","volume":"5","author":"Schornack","year":"2003","journal-title":"Neoplasia"},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Wefers, C., Duiveman-de Boer, T., Zusterzeel, P., Massuger, L., Fuchs, D., Torensma, R., Wheelock, C., and de Vries, I. (2018). Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010273"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4252\/wjsc.v11.i7.383","article-title":"Presence and Role of Stem Cells in Ovarian Cancer","volume":"11","author":"Suster","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7150\/jca.30410","article-title":"BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J. Cancer"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3892\/or.2014.2976","article-title":"Ovarian Cancer Stem Cell-Specific Gene Expression Profiling and Targeted Drug Prescreening","volume":"31","author":"Huang","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_301","doi-asserted-by":"crossref","unstructured":"Roberts, C.M., Cardenas, C., and Tedja, R. (2019). The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis. Cancers, 11.","DOI":"10.3390\/cancers11081083"},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Nam, E.J., Lee, M., Yim, G.W., Kim, J.H., Kim, S., Kim, S.W., and Kim, Y.T. (2012). MicroRNA Profiling of a CD133+spheroid-Forming Subpopulation of the OVCAR3 Human Ovarian Cancer Cell Line. BMC Med. Genom., 5.","DOI":"10.1186\/1755-8794-5-18"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-10-2388","article-title":"Double-Negative Feedback Loop between Reprogramming Factor LIN28 and MicroRNA Let-7 Regulates Aldehyde Dehydrogenase 1\u2013Positive Cancer Stem Cells","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Xu, C.-X., Xu, M., Tan, L., Yang, H., Permuth-Wey, J., Kruk, P.A., Wenham, R.M., Nicosia, S.V., Lancaster, J.M., and Sellers, T.A. (2016). MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting P53\/Nanog. J. Biol. Chem., 291.","DOI":"10.1074\/jbc.A112.374611"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA Expression Profiling in Human Ovarian Cancer: MiR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3892\/or.2014.3640","article-title":"Expression of MiR-136 Is Associated with the Primary Cisplatin Resistance of Human Epithelial Ovarian Cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","article-title":"MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer","volume":"69","author":"Bhattacharya","year":"2009","journal-title":"Cancer Res."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2016.11.017","article-title":"MicroRNA-136 Inhibits Cancer Stem Cell Activity and Enhances the Anti-Tumor Effect of Paclitaxel against Chemoresistant Ovarian Cancer Cells by Targeting Notch3","volume":"386","author":"Jeong","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3892\/ol.2017.6477","article-title":"Expression of MiR-146a in Patients with Ovarian Cancer and Its Clinical Significance","volume":"14","author":"Dzieniecka","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.18632\/oncotarget.7618","article-title":"Therapeutic Evaluation of MicroRNA-15a and MicroRNA-16 in Ovarian Cancer","volume":"7","author":"Dwivedi","year":"2016","journal-title":"Oncotarget"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","article-title":"Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","article-title":"Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer","volume":"77","author":"Zhao","year":"2017","journal-title":"Cancer Res."},{"key":"ref_313","doi-asserted-by":"crossref","unstructured":"Au Yeung, C.L., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S.-Y., Leung, C.S., Li, Y., Lu, E.S., Kwan, K., and Wong, K.-K. (2016). Exosomal Transfer of Stroma-Derived MiR21 Confers Paclitaxel Resistance in Ovarian Cancer Cells through Targeting APAF1. Nat. Commun., 7.","DOI":"10.1038\/ncomms11150"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fonc.2016.00125","article-title":"Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids","volume":"6","author":"Lopatina","year":"2016","journal-title":"Front. Oncol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccr.2010.06.016","article-title":"Regulation of Tumor Angiogenesis by EZH2","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41598-017-00966-3","article-title":"Therapeutic Targeting Using Tumor Specific Peptides Inhibits Long Non-Coding RNA HOTAIR Activity in Ovarian and Breast Cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-017-0430-x","article-title":"Suppression of Endothelial Cell Migration by Tumor Associated Macrophage-Derived Exosomes Is Reversed by Epithelial Ovarian Cancer Exosomal LncRNA","volume":"17","author":"Wu","year":"2017","journal-title":"Cancer Cell Int."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2017.02.009","article-title":"TWEAK-Stimulated Macrophages Inhibit Metastasis of Epithelial Ovarian Cancer via Exosomal Shuttling of MicroRNA","volume":"393","author":"Hu","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12935-019-0751-z","article-title":"MiR-1180 from Bone Marrow MSCs Promotes Cell Proliferation and Glycolysis in Ovarian Cancer Cells via SFRP1\/Wnt Pathway","volume":"19","author":"Hu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/s41388-019-0860-0","article-title":"MicroRNA-654-5p Suppresses Ovarian Cancer Development Impacting on MYC, WNT and AKT Pathways","volume":"38","author":"Majem","year":"2019","journal-title":"Oncogene"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"23748","DOI":"10.18632\/oncotarget.4250","article-title":"COL11A1 Confers Chemoresistance on Ovarian Cancer Cells through the Activation of Akt\/c\/EBP\u03b2 Pathway and PDK1 Stabilization","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopha.2015.02.020","article-title":"MiR-939 Promotes the Proliferation of Human Ovarian Cancer Cells by Repressing APC2 Expression","volume":"71","author":"Ying","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_323","first-page":"2631","article-title":"MicroRNA-16 Inhibits Migration and Invasion via Regulation of the Wnt\/\u0392-catenin Signaling Pathway in Ovarian Cancer","volume":"17","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gene.2017.09.012","article-title":"MicroRNA-219-5p Inhibits the Proliferation, Migration, and Invasion of Epithelial Ovarian Cancer Cells by Targeting the Twist\/Wnt\/\u03b2-Catenin Signaling Pathway","volume":"637","author":"Wei","year":"2017","journal-title":"Gene"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.humpath.2014.02.008","article-title":"Involvement of MiR-29b Signaling in the Sensitivity to Chemotherapy in Patients with Ovarian Carcinoma","volume":"45","author":"Dai","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1038\/onc.2017.185","article-title":"\u03b2-Catenin Downregulates Dicer to Promote Ovarian Cancer Metastasis","volume":"36","author":"To","year":"2017","journal-title":"Oncogene"},{"key":"ref_327","first-page":"3703","article-title":"Long Non-Coding RNA MALAT1 Regulates Ovarian Cancer Cell Proliferation, Migration and Apoptosis through Wnt\/\u03b2-Catenin Signaling Pathway","volume":"22","author":"Guo","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"He, S., Zhao, Y., Wang, X., Deng, Y., Wan, Z., Yao, S., and Shen, H. (2018). Up-Regulation of Long Non-Coding RNA SNHG20 Promotes Ovarian Cancer Progression via Wnt\/\u03b2-Catenin Signaling. Biosci. Rep., 38.","DOI":"10.1042\/BSR20170681"},{"key":"ref_329","first-page":"3369","article-title":"Long Non-Coding RNA CCAT2 Promotes Epithelial-Mesenchymal Transition Involving Wnt\/\u03b2-Catenin Pathway in Epithelial Ovarian Carcinoma Cells","volume":"15","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_330","first-page":"3615","article-title":"LncRNA AWPPH Promotes the Proliferation, Migration and Invasion of Ovarian Carcinoma Cells via Activation of the Wnt\/\u0392-catenin Signaling Pathway","volume":"19","author":"Yu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.biopha.2017.11.096","article-title":"LncRNA HOXD-AS1 Promotes Epithelial Ovarian Cancer Cells Proliferation and Invasion by Targeting MiR-133a-3p and Activating Wnt\/\u03b2-Catenin Signaling Pathway","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Zhuang, X., Liu, Y., and Li, J. (2019). Overexpression of Long Noncoding RNA HOXB-AS3 Indicates an Unfavorable Prognosis and Promotes Tumorigenesis in Epithelial Ovarian Cancer via Wnt\/\u03b2-Catenin Signaling Pathway. Biosci. Rep., 39.","DOI":"10.1042\/BSR20190906"},{"key":"ref_333","doi-asserted-by":"crossref","unstructured":"Vafaee, F., Colvin, E.K., Mok, S.C., Howell, V.M., and Samimi, G. (2017). Functional Prediction of Long Non-Coding RNAs in Ovarian Cancer-Associated Fibroblasts Indicate a Potential Role in Metastasis. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10869-y"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12935-021-02019-2","article-title":"LINC00115 Promotes Stemness and Inhibits Apoptosis of Ovarian Cancer Stem Cells by Upregulating SOX9 and Inhibiting the Wnt\/\u03b2-Catenin Pathway through Competitively Binding to MicroRNA-30a","volume":"21","author":"Hou","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_335","doi-asserted-by":"crossref","unstructured":"Su, C., and Huang, K. (2021). LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.649655"},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-20-0826","article-title":"Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1093\/hmg\/ddm018","article-title":"Epigenetic Gene Silencing in Cancer: The DNA Hypermethylome","volume":"16","author":"Esteller","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin Modifications and Their Function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0021-9258(17)35981-1","article-title":"DNA Methyltransferase Levels in Tumorigenic and Nontumorigenic Cells in Culture","volume":"261","author":"Kautiainen","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1158\/0008-5472.CAN-05-1187","article-title":"CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer","volume":"65","author":"Teodoridis","year":"2005","journal-title":"Cancer Res."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2003.10.028","article-title":"Hypermethylation of the PTEN Gene in Ovarian Cancer Cell Lines","volume":"207","author":"SCHONDORF","year":"2004","journal-title":"Cancer Lett."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.gore.2017.03.007","article-title":"Epigenetic Therapy for the Treatment of Epithelial Ovarian Cancer: A Clinical Review","volume":"20","author":"Smith","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-10-3035","article-title":"EMT and Stem Cell\u2013Like Properties Associated with MiR-205 and MiR-200 Epigenetic Silencing Are Early Manifestations during Carcinogen-Induced Transformation of Human Lung Epithelial Cells","volume":"71","author":"Tellez","year":"2011","journal-title":"Cancer Res."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41598-018-20004-0","article-title":"Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine","volume":"8","author":"Cai","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_345","doi-asserted-by":"crossref","unstructured":"Roca, M.S., di Gennaro, E., and Budillon, A. (2019). Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors. J. Clin. Med., 8.","DOI":"10.3390\/jcm8070912"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and Emerging HDAC Inhibitors for Cancer Treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_347","doi-asserted-by":"crossref","unstructured":"Zhang, W., Klinkebiel, D., Barger, C.J., Pandey, S., Guda, C., Miller, A., Akers, S.N., Odunsi, K., and Karpf, A.R. (2020). Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability. Cancers, 12.","DOI":"10.1101\/2020.01.22.20018374"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3389\/fonc.2020.599915","article-title":"How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer","volume":"10","author":"Ferraresi","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fcell.2020.00467","article-title":"Mitophagy, Mitochondrial Homeostasis, and Cell Fate","volume":"8","author":"Ma","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"17591","DOI":"10.18632\/oncotarget.7540","article-title":"The Multifaceted Role of Autophagy in Tumor Evasion from Immune Surveillance","volume":"7","author":"Janji","year":"2016","journal-title":"Oncotarget"},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.1218395","article-title":"Atg7 Modulates P53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress","volume":"336","author":"Lee","year":"2012","journal-title":"Science"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/0008-5472.CAN-18-2636","article-title":"Spleen Tyrosine Kinase\u2013Mediated Autophagy Is Required for Epithelial\u2013Mesenchymal Plasticity and Metastasis in Breast Cancer","volume":"79","author":"Shinde","year":"2019","journal-title":"Cancer Res."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","article-title":"Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An Overview of Autophagy: Morphology, Mechanism, and Regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ceb.2015.04.016","article-title":"Secretory Autophagy","volume":"35","author":"Ponpuak","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_356","first-page":"3917","article-title":"The Tumor Suppressor Gene ARHI Regulates Autophagy and Tumor Dormancy in Human Ovarian Cancer Cells","volume":"118","author":"Lu","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4161\/auto.28577","article-title":"DIRAS3 Regulates the Autophagosome Initiation Complex in Dormant Ovarian Cancer Cells","volume":"10","author":"Lu","year":"2014","journal-title":"Autophagy"},{"key":"ref_358","doi-asserted-by":"crossref","unstructured":"Galassi, C., Musella, M., Manduca, N., Maccafeo, E., and Sistigu, A. (2021). The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure. Cells, 10.","DOI":"10.3390\/cells10092361"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/0008-5472.CAN-09-1592","article-title":"Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells","volume":"70","author":"Schatton","year":"2010","journal-title":"Cancer Res."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients","volume":"16","author":"Mazzoleni","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_361","doi-asserted-by":"crossref","unstructured":"Morrison, B.J., Steel, J.C., and Morris, J.C. (2018). Reduction of MHC-I Expression Limits T-Lymphocyte-Mediated Killing of Cancer-Initiating Cells. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4389-3"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hed.21420","article-title":"Immunoregulatory Properties of CD44+ Cancer Stem-like Cells in Squamous Cell Carcinoma of the Head and Neck","volume":"33","author":"Chikamatsu","year":"2011","journal-title":"Head Neck"},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1158\/0008-5472.CAN-13-2563","article-title":"Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"key":"ref_364","doi-asserted-by":"crossref","unstructured":"Past\u00f2, A., Consonni, F.M., and Sica, A. (2020). Influence of Innate Immunity on Cancer Cell Stemness. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093352"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2014.00360","article-title":"Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?","volume":"5","author":"Bruttel","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.142298299","article-title":"Characterization of the Expression of MHC Proteins in Human Embryonic Stem Cells","volume":"99","author":"Drukker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4103\/jcrt.JCRT_976_17","article-title":"Therapeutic Approaches Targeting Cancer Stem Cells","volume":"14","author":"Pan","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP Family of Receptors and Immune Regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 Immune Checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-14-1399","article-title":"Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms","volume":"21","author":"Cioffi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.27070","article-title":"Blockade of CD47-Mediated Cathepsin S\/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma","volume":"60","author":"Lee","year":"2014","journal-title":"Hepatology"},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.stem.2016.12.001","article-title":"Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression","volume":"20","author":"Alvarado","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_373","doi-asserted-by":"crossref","unstructured":"Shang, B., Liu, Y., Jiang, S., and Liu, Y. (2015). Prognostic Value of Tumor-Infiltrating FoxP3+ Regulatory T Cells in Cancers: A Systematic Review and Meta-Analysis. Sci. Rep., 5.","DOI":"10.1038\/srep15179"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2018.09.006","article-title":"The Role of Cancer Stem Cells in the Modulation of Anti-Tumor Immune Responses","volume":"53","author":"Maccalli","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.tcb.2019.01.003","article-title":"Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy","volume":"29","author":"Vitale","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/0008-5472.CAN-06-1627","article-title":"Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1","volume":"67","author":"Saudemont","year":"2007","journal-title":"Cancer Res."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1038\/ncomms6238","article-title":"CD95 and CD95L Promote and Protect Cancer Stem Cells","volume":"5","author":"Ceppi","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of Tumor-Associated Neutrophil Phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_380","first-page":"113","article-title":"Cancer-Associated Myeloid Regulatory Cells","volume":"7","author":"Goyvaerts","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-Associated Macrophages as Treatment Targets in Oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.1039\/D0TB02312D","article-title":"Enrichment of Cancer-Initiating Cells from Colon Cancer Cells through Porous Polymeric Membranes by a Membrane Filtration Method","volume":"8","author":"Sung","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s12015-020-09995-4","article-title":"Emerging Importance of Survivin in Stem Cells and Cancer: The Development of New Cancer Therapeutics","volume":"16","author":"Warrier","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/0008-5472.CAN-07-2249","article-title":"MCF7 Side Population Cells with Characteristics of Cancer Stem\/Progenitor Cells Express the Tumor Antigen MUC1","volume":"68","author":"Engelmann","year":"2008","journal-title":"Cancer Res."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00262-009-0672-0","article-title":"Cancer\/Testis Antigens Can Be Immunological Targets in Clonogenic CD133+ Melanoma Cells","volume":"58","author":"Gedye","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_386","doi-asserted-by":"crossref","unstructured":"Chang, C.-L., Wu, C.-C., Hsu, Y.-T., and Hsu, Y.-C. (2020). Immune Vulnerability of Ovarian Cancer Stem-like Cells Due to Low CD47 Expression Is Protected by Surrounding Bulk Tumor Cells. OncoImmunology, 9.","DOI":"10.1080\/2162402X.2020.1803530"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.ajpath.2011.01.004","article-title":"Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells","volume":"178","author":"Inoda","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed Cell Death 1 Ligand 1 and Tumor-Infiltrating CD8+ T Lymphocytes Are Prognostic Factors of Human Ovarian Cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_389","doi-asserted-by":"crossref","unstructured":"Yu, L., Ding, Y., Wan, T., Deng, T., Huang, H., and Liu, J. (2021). Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.768115"},{"key":"ref_390","doi-asserted-by":"crossref","unstructured":"Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D.M., Poggi, A., Bruno, A., and Mortara, L. (2020). The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093125"},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.25156","article-title":"ULBP2 and RAET1E NKG2D Ligands Are Independent Predictors of Poor Prognosis in Ovarian Cancer Patients","volume":"127","author":"McGilvray","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI200422206","article-title":"Prevalent Expression of the Immunostimulatory MHC Class I Chain\u2013Related Molecule Is Counteracted by Shedding in Prostate Cancer","volume":"114","author":"Wu","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-008-0585-3","article-title":"Clinical Significance of the NKG2D Ligands, MICA\/B and ULBP2 in Ovarian Cancer: High Expression of ULBP2 Is an Indicator of Poor Prognosis","volume":"58","author":"Li","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neo.2017.03.005","article-title":"Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells","volume":"19","author":"Cai","year":"2017","journal-title":"Neoplasia"},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-Derived Soluble MIC Ligands Impair Expression of NKG2D and T-Cell Activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00262-017-1958-2","article-title":"Dendritic Cell Rehab: New Strategies to Unleash Therapeutic Immunity in Ovarian Cancer","volume":"66","author":"Chae","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian Cancer Development and Metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An Evolving Story of the Metastatic Voyage of Ovarian Cancer Cells: Cellular and Molecular Orchestration of the Adipose-Rich Metastatic Microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"ref_399","doi-asserted-by":"crossref","unstructured":"Pereira, M., Matuszewska, K., Jamieson, C., and Petrik, J. (2021). Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.772349"},{"key":"ref_400","doi-asserted-by":"crossref","unstructured":"R\u00e5destad, E., Klynning, C., Stikvoort, A., Mogensen, O., Nava, S., Magalhaes, I., and Uhlin, M. (2019). Immune Profiling and Identification of Prognostic Immune-Related Risk Factors in Human Ovarian Cancer. OncoImmunology, 8.","DOI":"10.1080\/2162402X.2018.1535730"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The Unique Molecular and Cellular Microenvironment of Ovarian Cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10555-015-9594-9","article-title":"Neutrophils: Important Contributors to Tumor Progression and Metastasis","volume":"34","author":"Swierczak","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"ref_403","first-page":"246","article-title":"Constitutive Expression of TGF-B\u00eata1, Interleukin-6 and Interleukin-8 by Tumor Cells as a Major Component of Immune Escape in Human Ovarian Carcinoma","volume":"14","author":"Toutirais","year":"2003","journal-title":"Eur. Cytokine Netw."},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2","volume":"39","author":"Cui","year":"2013","journal-title":"Immunity"},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 Macrophages: Oracles of Health and Disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.3892\/mmr.2015.3323","article-title":"Ovarian Cancer Stem-like Cells Elicit the Polarization of M2 Macrophages","volume":"11","author":"ZHANG","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"375","DOI":"10.20892\/j.issn.2095-3941.2018.0062","article-title":"Human Epidermal Growth Factor Receptor Targeted Inhibitors for the Treatment of Ovarian Cancer","volume":"15","author":"Bonello","year":"2018","journal-title":"Cancer Biol Med"},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"75763","DOI":"10.18632\/oncotarget.12409","article-title":"Hypoxia-Induced CCL28 Promotes Recruitment of Regulatory T Cells and Tumor Growth in Liver Cancer","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cei.13044","article-title":"Ovarian Cancer Stem Cells Promote Tumour Immune Privilege and Invasion via CCL5 and Regulatory T Cells","volume":"191","author":"You","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jcp.22761","article-title":"Hypoxia Affects Dendritic Cell Survival: Role of the Hypoxia-Inducible Factor-1\u03b1 and Lipopolysaccharide","volume":"227","author":"Naldini","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41598-018-21891-z","article-title":"HIF-1\u03b1 Hampers Dendritic Cell Function and Th1 Generation during Chronic Visceral Leishmaniasis","volume":"8","author":"Hammami","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4252\/wjsc.v10.i12.183","article-title":"Cancer Stem Cell Impact on Clinical Oncology","volume":"10","year":"2018","journal-title":"World J. Stem Cells"},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2147\/OTT.S155458","article-title":"Are Ovarian Cancer Stem Cells the Target for Innovative Immunotherapy?","volume":"11","author":"Wang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-Cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/stem.3004","article-title":"Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses","volume":"37","author":"Crupi","year":"2019","journal-title":"Stem Cells"},{"key":"ref_416","first-page":"2344","article-title":"Development of Anticancer Agents Targeting the Wnt\/\u03b2-Catenin Signaling","volume":"5","author":"Zhang","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_417","doi-asserted-by":"crossref","unstructured":"Doo, D.W., Meza-Perez, S., Londo\u00f1o, A.I., Goldsberry, W.N., Katre, A.A., Boone, J.D., Moore, D.J., Hudson, C.T., Betella, I., and McCaw, T.R. (2020). Inhibition of the Wnt\/\u03b2-Catenin Pathway Enhances Antitumor Immunity in Ovarian Cancer. Ther. Adv. Med. Oncol., 12.","DOI":"10.1177\/1758835920913798"},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1158\/1078-0432.CCR-12-1796","article-title":"A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission","volume":"18","author":"Kaye","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2015.11.021","article-title":"A First-in-Human Phase I Study of the Oral Notch Inhibitor, LY900009, in Patients with Advanced Cancer","volume":"56","author":"Pant","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2015.12.011","article-title":"Sequential Combination Therapy of Ovarian Cancer with Cisplatin and \u03b3-Secretase Inhibitor MK-0752","volume":"140","author":"Chen","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41416-020-1026-0","article-title":"Tumour-Associated Neutrophils Orchestrate Intratumoural IL-8-Driven Immune Evasion through Jagged2 Activation in Ovarian Cancer","volume":"123","author":"Yang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2015.03.005","article-title":"A Phase II Study of Single-Agent RO4929097, a Gamma-Secretase Inhibitor of Notch Signaling, in Patients with Recurrent Platinum-Resistant Epithelial Ovarian Cancer: A Study of the Princess Margaret, Chicago and California Phase II Consortia","volume":"137","author":"Wilson","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-14-2797","article-title":"A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors","volume":"21","author":"Chiorean","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ygyno.2020.01.042","article-title":"Demcizumab Combined with Paclitaxel for Platinum-Resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: The SIERRA Open-Label Phase Ib Trial","volume":"157","author":"Coleman","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10637-018-0665-y","article-title":"A First-in-Human Phase 1a Study of the Bispecific Anti-DLL4\/Anti-VEGF Antibody Navicixizumab (OMP-305B83) in Patients with Previously Treated Solid Tumors","volume":"37","author":"Jimeno","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_426","doi-asserted-by":"crossref","unstructured":"Lee, H.-G., Shin, S.-J., Chung, H.-W., Kwon, S.-H., Cha, S.-D., Lee, J.-E., and Cho, C.-H. (2017). Salinomycin Reduces Stemness and Induces Apoptosis on Human Ovarian Cancer Stem Cell. J. Gynecol. Oncol., 28.","DOI":"10.3802\/jgo.2017.28.e14"},{"key":"ref_427","doi-asserted-by":"crossref","unstructured":"Michalak, M., Lach, M.S., Antoszczak, M., Huczy\u0144ski, A., and Suchorska, W.M. (2020). Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives\u2014An In Vitro Study. Molecules, 25.","DOI":"10.3390\/molecules25030537"},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fonc.2020.00319","article-title":"Novel Therapeutic Strategies for Ovarian Cancer Stem Cells","volume":"10","author":"Terraneo","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.21037\/atm-20-1060","article-title":"Metformin and Ovarian Cancer: The Evidence","volume":"8","author":"Urpilainen","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_430","doi-asserted-by":"crossref","unstructured":"Michy, T., Massias, T., Bernard, C., Vanwonterghem, L., Henry, M., Guidetti, M., Royal, G., Coll, J.-L., Texier, I., and Josserand, V. (2019). Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo. Cancers, 11.","DOI":"10.3390\/cancers11111760"},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2005.09.041","article-title":"Phase II Trial of Imatinib Mesylate in Patients with Recurrent Platinum- and Taxane-Resistant Epithelial Ovarian and Primary Peritoneal Cancers","volume":"101","author":"Coleman","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5468\/ogs.2016.59.4.261","article-title":"The Effect of Salinomycin on Ovarian Cancer Stem-like Cells","volume":"59","author":"Chung","year":"2016","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_433","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2013.05.027","article-title":"Targeting CD133 in an in Vivo Ovarian Cancer Model Reduces Ovarian Cancer Progression","volume":"130","author":"Skubitz","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.7150\/thno.51885","article-title":"Aldehyde Dehydrogenase Inhibitors Promote DNA Damage in Ovarian Cancer and Synergize with ATM\/ATR Inhibitors","volume":"11","author":"Grimley","year":"2021","journal-title":"Theranostics"},{"key":"ref_435","doi-asserted-by":"crossref","unstructured":"Nwani, N., Condello, S., Wang, Y., Swetzig, W., Barber, E., Hurley, T., and Matei, D. (2019). A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer. Cancers, 11.","DOI":"10.3390\/cancers11040502"},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-11-0023","article-title":"Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells","volume":"10","author":"Alvero","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00262-004-0569-x","article-title":"In Vivo Cervical Cancer Growth Inhibition by Genetically Engineered Cytotoxic T Cells","volume":"54","author":"Dall","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.18632\/oncotarget.14592","article-title":"Intraperitoneal Immunotherapy with T Cells Stably and Transiently Expressing Anti-EpCAM CAR in Xenograft Models of Peritoneal Carcinomatosis","volume":"8","author":"Ang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/hum.2017.168","article-title":"Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor\u2013Based Immunotherapy and Chemotherapy","volume":"28","author":"Klapdor","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_440","doi-asserted-by":"crossref","unstructured":"Cacan, E., Ali, M.W., Boyd, N.H., Hooks, S.B., and Greer, S.F. (2014). Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087455"},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12967-015-0722-7","article-title":"Gene Methylation of Human Ovarian Carcinoma Stromal Progenitor Cells Promotes Tumorigenesis","volume":"13","author":"Ho","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/cncr.25204","article-title":"A Phase 1 and Pharmacodynamic Study of Decitabine in Combination with Carboplatin in Patients with Recurrent, Platinum-Resistant, Epithelial Ovarian Cancer","volume":"116","author":"Fang","year":"2010","journal-title":"Cancer"},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/bjc.2014.116","article-title":"A Randomised, Phase II Trial of the DNA-Hypomethylating Agent 5-Aza-2\u2032-Deoxycytidine (Decitabine) in Combination with Carboplatin vs Carboplatin Alone in Patients with Recurrent, Partially Platinum-Sensitive Ovarian Cancer","volume":"110","author":"Glasspool","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/0008-5472.CAN-11-3909","article-title":"Epigenetic Resensitization to Platinum in Ovarian Cancer","volume":"72","author":"Matei","year":"2012","journal-title":"Cancer Res."},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-19-3837","article-title":"Epigenetic Attire in Ovarian Cancer: The Emperor\u2019s New Clothes","volume":"80","author":"Matei","year":"2020","journal-title":"Cancer Res."},{"key":"ref_446","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Mei, Q., Liu, Y., Li, X., Brock, M.V., Chen, M., Dong, L., Shi, L., Wang, Y., and Guo, M. (2017). The Safety, Efficacy, and Treatment Outcomes of a Combination of Low-Dose Decitabine Treatment in Patients with Recurrent Ovarian Cancer. OncoImmunology, 6.","DOI":"10.1080\/2162402X.2017.1323619"},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/2326-6066.CIR-13-0126","article-title":"Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer","volume":"2","author":"Odunsi","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-19-1638","article-title":"A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer","volume":"26","author":"Oza","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-18-4018","article-title":"DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer","volume":"79","author":"Travers","year":"2019","journal-title":"Cancer Res."},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/cncr.25701","article-title":"Phase 1b-2a Study to Reverse Platinum Resistance through Use of a Hypomethylating Agent, Azacitidine, in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer","volume":"117","author":"Fu","year":"2011","journal-title":"Cancer"},{"key":"ref_451","first-page":"1245","article-title":"Three Combined Treatments, a Novel HDAC Inhibitor OBP-801\/YM753, 5-Fluorouracil, and Paclitaxel, Induce G 2 Phase Arrest Through the P38 Pathway in Human Ovarian Cancer Cells","volume":"25","author":"Akiyama","year":"2017","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2008.01.009","article-title":"A Phase II Study of Vorinostat in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study","volume":"109","author":"Modesitt","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00280-015-2813-9","article-title":"Phase I Study of Combination of Vorinostat, Carboplatin, and Gemcitabine in Women with Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer","volume":"76","author":"Matulonis","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/IGC.0b013e31828566f1","article-title":"Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer","volume":"23","author":"Mendivil","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ejca.2010.02.047","article-title":"Phase II Trial of the Histone Deacetylase Inhibitor Belinostat in Women with Platinum Resistant Epithelial Ovarian Cancer and Micropapillary (LMP) Ovarian Tumours","volume":"46","author":"Mackay","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/IGC.0b013e31825736fd","article-title":"Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer","volume":"22","author":"Dizon","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2011.12.425","article-title":"The Impact of Novel Retinoids in Combination with Platinum Chemotherapy on Ovarian Cancer Stem Cells","volume":"125","author":"Whitworth","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10585-012-9562-5","article-title":"Inhibition of Focal Adhesion Kinase (FAK) Activity Prevents Anchorage-Independent Ovarian Carcinoma Cell Growth and Tumor Progression","volume":"30","author":"Ward","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1038\/oncsis.2016.86","article-title":"Inhibition of the Integrin\/FAK Signaling Axis and c-Myc Synergistically Disrupts Ovarian Cancer Malignancy","volume":"6","author":"Xu","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1158\/1078-0432.CCR-17-3697","article-title":"Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells","volume":"24","author":"Simpkins","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_461","doi-asserted-by":"crossref","unstructured":"Falchook, G., Infante, J., Arkenau, H.-T., Patel, M.R., Dean, E., Borazanci, E., Brenner, A., Cook, N., Lopez, J., and Pant, S. (2021). First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of First-in-Class Fatty Acid Synthase Inhibitor TVB-2640 Alone and with a Taxane in Advanced Tumors. EClinicalMedicine, 34.","DOI":"10.1016\/j.eclinm.2021.100797"},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2019.04.001","article-title":"A Phase 1b Dose Escalation Study of Ipafricept (OMP 54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer","volume":"154","author":"Moore","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10637-017-0454-z","article-title":"Phase I Trial of the Oral Smoothened Inhibitor Sonidegib in Combination with Paclitaxel in Patients with Advanced Solid Tumors","volume":"35","author":"Stathis","year":"2017","journal-title":"Investig. New Drugs"},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In Vitro Metformin Anti-Neoplastic Activity in Epithelial Ovarian Cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_465","doi-asserted-by":"crossref","unstructured":"Brown, J.R., Chan, D.K., Shank, J.J., Griffith, K.A., Fan, H., Szulawski, R., Yang, K., Reynolds, R.K., Johnston, C., and McLean, K. (2020). Phase II Clinical Trial of Metformin as a Cancer Stem Cell-Targeting Agent in Ovarian Cancer. JCI Insight, 5.","DOI":"10.1172\/jci.insight.133247"},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1200\/JCO.2007.14.3420","article-title":"Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study","volume":"26","author":"Schilder","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2012.02.034","article-title":"Phase II Trial of Imatinib Mesylate in Patients with Recurrent Platinum- and Taxane-Resistant Low-Grade Serous Carcinoma of the Ovary, Peritoneum, or Fallopian Tube","volume":"125","author":"Noguera","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1200\/JCO.2019.37.15_suppl.5511","article-title":"A Phase II Randomized Study of Avelumab plus Entinostat versus Avelumab plus Placebo in Patients (Pts) with Advanced Epithelial Ovarian Cancer (EOC)","volume":"37","author":"Cadoo","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1200\/jco.2014.32.15_suppl.5521","article-title":"Phase 1\/1b Study of the FAK Inhibitor Defactinib (VS-6063) in Combination with Weekly Paclitaxel for Advanced Ovarian Cancer","volume":"32","author":"Patel","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13048-015-0196-5","article-title":"Effect of Targeted Ovarian Cancer Immunotherapy Using Ovarian Cancer Stem Cell Vaccine","volume":"8","author":"Wu","year":"2015","journal-title":"J. Ovarian Res."},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/mabs.2.2.11221","article-title":"Catumaxomab","volume":"2","author":"Linke","year":"2010","journal-title":"mAbs"},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-11-2235","article-title":"Immunomonitoring Results of a Phase II\/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM \u00d7 Anti-CD3)","volume":"72","author":"Schoberth","year":"2012","journal-title":"Cancer Res."},{"key":"ref_473","doi-asserted-by":"crossref","unstructured":"Leary, A., Tan, D., and Ledermann, J. (2021). Immune Checkpoint Inhibitors in Ovarian Cancer: Where Do We Stand?. Ther. Adv. Med. Oncol., 13.","DOI":"10.1177\/17588359211039899"},{"key":"ref_474","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.21.00306","article-title":"Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050\/GOG 3015\/ENGOT-OV39)","volume":"39","author":"Moore","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair\u2013Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/1078-0432.CCR-06-1183","article-title":"A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer","volume":"12","author":"Kershaw","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_477","doi-asserted-by":"crossref","unstructured":"Klapdor, R., Wang, S., Morgan, M.A., Zimmermann, K., Hachenberg, J., B\u00fcning, H., D\u00f6rk, T., Hillemanns, P., and Schambach, A. (2021). NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101339"},{"key":"ref_478","doi-asserted-by":"crossref","unstructured":"Hartnett, E.G., Knight, J., Radolec, M., Buckanovich, R.J., Edwards, R.P., and Vlad, A.M. (2020). Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers, 12.","DOI":"10.3390\/cancers12123733"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/5\/2496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:26:40Z","timestamp":1760135200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/5\/2496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":478,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23052496"],"URL":"https:\/\/doi.org\/10.3390\/ijms23052496","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]}}}